Evaluation Freethiadine Tolerance in Healthy Subjects and Patients With Chronic Hepatitis B, Pharmacokinetics Characteristics and Antiviral Activity of Ⅰ Phase of Study
Clinical trial NCT05391360 · COMPLETED
Trial details
- NCT number
- NCT05391360
- Sponsor
- Sunshine Lake Pharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-11
- Primary completion
- 2023-01-17
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.